Monument Therapeutics

Monument Tx is a neuroscience-focused drug development company using digital biomarkers to develop more targeted treatments for psychiatric and neurological disorders. Lead program MT1988 is currently in a large patient study in clinical high risk for psychosis individuals to assess its potential to improve cognitive impairment associated with schizophrenia and validate its predictive digital biomarker.